Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older-Reference-Cited by-同舟云学术

Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older

Published:2017-09-26 Issue:11 Volume:216 Page:1352-1361
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Schwarz Tino F¹,Aggarwal Naresh²,Moeckesch Beate³,Schenkenberger Isabelle⁴,Claeys Carine⁵,Douha Martine⁵,Godeaux Olivier⁶,Grupping Katrijn⁵,Heineman Thomas C⁷⁸,Fauqued Marta Lopez⁵,Oostvogels Lidia⁵,Van den Steen Peter⁵,Lal Himal⁷⁹

Affiliation:

1. Central Laboratory and Vaccination Centre, Klinikum Würzburg Mitte, Standort Juliusspital, Würzburg

2. Aggarwal and Associates, Brampton, Ontario, Canada

3. Gemeinschaftspraxis Dr Michael und Dr Beate Möckesch, Weinheim

4. Klinische Forschung, Berlin, Germany

5. GSK Vaccines, Wavre, Belgium

6. Janssen Vaccines & Prevention, Leiden, the Netherlands

7. GSK Vaccines, King of Prussia, Pennsylvania

8. Present affiliation: Genocea Biosciences, Cambridge, Massachusetts

9. Present affiliation: Pfizer Inc, Collegeville, Pennsylvania

Publisher

Oxford University Press (OUP)